TY  - GEN
AU  - Sterling,Timothy R
AU  - Villarino,M Elsa
AU  - Borisov,Andrey S
AU  - Shang,Nong
AU  - Gordin,Fred
AU  - Bliven-Sizemore,Erin
AU  - Hackman,Judith
AU  - Hamilton,Carol Dukes
AU  - Menzies,Dick
AU  - Kerrigan,Amy
AU  - Weis,Stephen E
AU  - Weiner,Marc
AU  - Wing,Diane
AU  - Conde,Marcus B
AU  - Bozeman,Lorna
AU  - Horsburgh,C Robert
AU  - Chaisson,Richard E
TI  - Three months of rifapentine and isoniazid for latent tuberculosis infection
SN  - 1533-4406
PY  - 2011///1220
KW  - Adult
KW  - Antitubercular Agents
KW  - administration & dosage
KW  - Directly Observed Therapy
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Follow-Up Studies
KW  - Humans
KW  - Intention to Treat Analysis
KW  - Isoniazid
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Rifampin
KW  - Risk Factors
KW  - Self Administration
KW  - Tuberculosis
KW  - drug therapy
KW  - Virus Latency
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1056/NEJMoa1104875
ER  -